- Report
- July 2024
- 150 Pages
Global
From €5247EUR$5,950USD£4,526GBP
- Report
- March 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- June 2025
- 150 Pages
Global
From €3395EUR$3,850USD£2,929GBP
- Report
- July 2025
- 487 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,765GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1323EUR$1,500USD£1,141GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1764EUR$2,000USD£1,521GBP
- Report
- April 2025
- 192 Pages
Global
From €4405EUR$4,995USD£3,800GBP
- Report
- July 2025
- 563 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,122GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,122GBP
- Report
- July 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- September 2023
- 120 Pages
Global
From €5247EUR$5,950USD£4,526GBP
- Report
- May 2023
- 260 Pages
Global
From €2337EUR$2,650USD£2,016GBP
- Report
- May 2024
- 137 Pages
Global
From €5732EUR$6,499USD£4,944GBP
- Report
- May 2024
- 135 Pages
Global
From €5732EUR$6,499USD£4,944GBP
- Report
- February 2024
- 180 Pages
Global
From €4382EUR$4,969USD£3,780GBP
- Report
- June 2024
- 200 Pages
Global
From €7011EUR$7,950USD£6,048GBP
- Report
- January 2022
- 60 Pages
Global
From €3484EUR$3,950USD£3,005GBP
- Report
- April 2024
- 185 Pages
Global
From €3373EUR$3,825USD£2,910GBP
€3969EUR$4,500USD£3,423GBP

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more